Executive Director
Mr. Zhang Feng
Appointed as an executive director, the chairman of the Board and compliance officer of the Company since June 2011, and was appointed as the authorized representative of the Company on 8 February 2021. He obtained an MBA degree from University of Technology, Sydney. Mr. Zhang studied in Göteborg University, Sweden. He was a member of the 13th National Committee of Chinese People’s Political Conference, a committee member of the 10th and 11th and a standing committee member of the 12th Jilin Municipal Provincial Committee of the Chinese People’s Political Consultative Conference, a standing committee member of the 14th Jilin Provincial People’s Congress, the deputy chairman of the 10th, 11th and 12th sessions of Jilin Youth Federation (吉林省青年联合会), the president of the 8th session and the honorary president of the 9th session of council of Jilin Province Youth Entrepreneurs Association (吉林省青年企业家协会) and the part-time deputy chairman of the 11th Jilin Federation of Industry and Commerce (吉林省工商联). Mr. Zhang was the general manager of Shenzhen Neptunus Pharmaceutical Co., Ltd. (“Neptunus Pharmaceutical”) and Shenzhen Neptunus Tongai Pharmaceutical Manufacturing Company Ltd. and the deputy general manager and chief branding and marketing officer of Shenzhen Neptunus Bio-engineering Company Limited (“Neptunus Bio-engineering”). He is currently the chairman and non-independent director of the 10th session of the Board of Directors, the president, the chairman of the strategy development and research committee, the chairman of the budget committee, a member of the Remuneration and Evaluation Committee and a member of the nomination committee of Neptunus Bio-engineering, the director of Shenzhen Neptunus Group Company Limited (“Neptunus Group”) and Ascendent BioTechnology Company Limited, the chairman of the Board of Directors of Shenzhen Neptunus Changjian Pharmaceutical Co., Ltd. (“Neptunus Changjian”), the chairman of the Board of Directors of Neptunus Pharmaceutical, the director of Neptunus Fuyao and Neptunus Jinxiang and the chairman of the Board of Directors and director of several other companies.
Mr. Huang Jian Bo
Appointed as an executive director of the Company, joint company secretary and authorized representative of the Company since June 2020, vice general manager of the Company since 24 April 2020 and the Board secretary and the financial controller of the Company since 13 May 2020. Mr. Huang graduated from Hunan University with a bachelor’s degree in economics and majoring in finance and is a member of the Chinese Institute of Certified Public Accountants. He has extensive experience in listing operations, financial management and investment management. Mr Huang has worked in the Company during the period from February 2003 to April 2016, and served as the chief financial officer, joint company secretary, Board secretary and authorised representative of the Company. He was the financial controller of each of Anhui Jiuhua Huayuan Pharmaceutical Co., Ltd. (安徽九华华源药业有限公司) and Shenzhen Ainengsen Technology Co., Ltd. (深圳爱能森科技有限公司). Mr. Huang is currently a director of Neptunus Changjian and the chairman of supervisory committee of Neptunus Zhongxin.
Mr. Zhang Xiao Guang
Appointed as an executive director of the Company since 25 June 2023. Mr. Zhang graduated from China FAW Group Workers College (中国第一汽车集团职工大学), majoring in mechanical and electrical automation. He has been working in the pharmaceutical industry for over 20 years and officially joined the Neptunus Group in 2009. Mr. Zhang has extensive experience in sales management and has won multiple awards in the industry, including the Outstanding Management Team Award and Excellent Manager Award of the OTC Sales Department of Neptunus Changjian. He has served as the sales manager, the provincial manager of Shanxi and Jilin provinces, the sales director of the north China region, and the deputy national sales supervisor and deputy national sales general manager of Neptunus Changjian. Currently, he is the legal representative, director and general manager of
Neptunus Changjian and a director of Neptunus Zhongxin, Neptunus Fuyao, Neptunus Jinxiang and several other companies.
Non-Executive Director
Mr. Zhang Yi Fei
Appointed as a non-executive Director of the Company since 1 March 2021. Mr. Zhang obtained his bachelor’s degree in Technical Economics in 1996 and a master’s degree in Management Science and Engineering in 2015 from the School of Management, Harbin Institute of Technology. He previously served in various roles, including secretary of the president’s office of Neptunus Group, regional sales manager of Heilongjiang province, manager of the northeast region, nationwide commercial director, assistant general manager and operations director of Neptunus Bio-engineering. He had also acted as the general manager of Zhejiang Huafang Life Technology Co., Ltd. (浙江华方生命科技有限公司) and a director of Neptunus Pharmaceutical, Shenzhen Neptunus Jiankang Technology Development Co., Ltd and Shenzhen Neptunus Yinhe Pharmaceutical Investment Co., Ltd. Mr. Zhang is currently the deputy chairman and non-independent director of the 10th session of the Board of Directors, the executive vice president, a member of the budget committee, a member of the nomination committee and a member of the strategy development and research committee of Neptunus Bio-engineering, the legal representative, chairman of the Board of Directors and general manager of Jilin Neptunus Yinhe Pharmaceutical Investment Co., Ltd., the chairman of the Board of Directors of Neptunus Fuyao and Neptunus Zhongxin, and a director of several other companies.
Mr. Jin Rui
Appointed as a non-executive director of the Company since 13 May 2022. Mr. Jin obtained a bachelor’s degree from Nanjing University in 2007 and a master’s degree from Zhejiang University in 2013. Mr. Jin previously served various roles in the management level in a number of companies, including the assistant president of Holley Group Co., Ltd., the vice president of Holley Pharmaceutical Group Co., Ltd, and a director of Zhejiang Wazam New Materials Co., Ltd. and Anhui Neptunus Pharmaceutical Group Co., Ltd. He is currently the vice president and non-independent director and a member of the budget committee of Neptunus Bio-engineering and a director of Neptunus Fuyao, Neptunus Jinxiang and Neptunus Zhongxin and several other companies.
Mr. Zhang Xiao Peng
Appointed as a non-executive director of the Company since 25 June 2026. Mr. Zhang graduated from Zhongnan Institute of Politics and Law in June 1993, majoring in Economic Law. He obtained a Master of Laws degree from Zhongnan University of Economics and Law in June 2002, and completed graduate studies in economic management from the Party School of the Central Committee of the Communist Party of China. Mr. Zhang commenced his career in July 1993 and has successively served as deputy section chief and section chief, squadron leader of criminal police, deputy station chief, station chief, political commissar of the patrol police brigade, director of the political office of Nanshan Branch of the Public Security Bureau of Shenzhen Municipal, and director of the personnel division of the political department of the Public Security Bureau of Shenzhen Municipal. Mr. Zhang possesses extensive front-line law enforcement experience and has conducted in-depth research in the field of economic crimes. With a strong sense of innovation and familiarity with public administration affairs, he participated in the design of the reform framework of the Shenzhen public security system, specifically took charge of the reform of the auxiliary police in Shenzhen, and drafted the Regulations of Shenzhen Special Economic Zone on Auxiliary Police. He was awarded the Individual Third Class Merit on three occasions and named Outstanding Police Officer of Guangdong Province. He currently serves as vice president of Neptunus Bio-engineering, chairman of Guangdong Neptunus Pharmaceutical Group Co., Ltd., chairman of Hubei Neptunus Pharmaceutical Group Co., Ltd., executive director of Henan Neptunus Pharmaceutical Group Co., Ltd., and holds directorships in various subsidiaries. Mr. Zhang has accumulated extensive experience in public administration, corporate management and team building, and has received repeated industry recognition.
Independent Non-Executive Directors
Mr. Yick Wing Fat, Simon
Appointed as an independent non-executive director of the Company since August 2005. Mr. Yick holds a bachelor’s degree in business administration, majoring in accounting, from the Chinese University of Hong Kong. He is a fellow member of both the Hong Kong Institute of Certified Public Accountants and the Association of Chartered Certified Accountants in England. Mr. Yick has more than 30 years of experience in auditing, direct investment, investment banking and corporate advisory services. Mr. Yick was an independent non-executive director, the chairman of the remuneration and nomination committee and a member of the audit and compliance committee of Nexteer Automotive Group Limited (the shares of which are listed on the Main Board of the Stock Exchange, stock code: 1316) from August 2017 to June 2022, an independent non-executive director, a member of the nomination committee and the remuneration committee, and the chairman of the audit committee of Shanghai International Shanghai Growth Investment Limited (a company listed on the Main Board of the Stock Exchange, stock code: 770) from July 1999 to February 2025, and an independent non-executive director, a member of the nomination committee and the remuneration committee, and the chairman of the audit committee of China Shuifa Singyes Energy Holdings Limited (the shares of which are listed on the Main Board of the Stock Exchange, stock code: 750) from 2008 to 23 September 2025. Mr. Yick is currently an independent non-executive director, a member of the nomination committee and the chairman of each of the audit and remuneration committees of Meta Media Holdings Limited (formerly known as “Modern Media Holdings Limited”) (the shares of which are listed on the Main Board of the Stock Exchange, stock code: 72).
Mr. Poon Ka Yeung
Appointed as an independent non-executive Director of the Company since August 2005. Mr. Poon obtained his bachelor’s degree in mathematics with a minor in economics and marketing from the Chinese University of Hong Kong in 1989 and was further admitted to the MBA degree by the University of Hull, United Kingdom, in 1996. Mr. Poon has been appointed as an Honorary Institute Fellow of the Asia-Pacific Institute of Business of the Chinese University of Hong Kong since April 2002. He has been teaching marketing-related subjects for the master’s degree in science program, MBA program and Executive EMBA program of the Chinese University of Hong Kong. Since June 2008, he has been appointed as a visiting Adjunct Associate Professor in the Department of Marketing of the Chinese University of Hong Kong. In addition, Mr. Poon was appointed as an independent non-executive director and a member of audit, remuneration and nomination committees of Great Eagle Holdings Limited (the shares of which are listed on the Main Board of the Stock Exchange, stock code: 41) from March 2016 to December 2021. On 22 December 2021, Mr. Poon was re-designated as an executive director of Great Eagle Holdings Limited, presiding over innovative technology and investment.
Ms. Zhu Jia Min
Appointed as an independent non-executive Director of the Company since 25 June 2026. Ms. Zhu graduated from China West Normal University in 2016, majoring in fine arts education. She obtained certificate of accounting professional in 2007 and law practice qualification certificate in 2024. She served as a sales director at Ciprun Network Technology (Jiangsu) Co., Ltd.* (中细软网络科技(江苏)有限公司) from April 2011 to December 2012, as an assistant to the general manager at Beijing SYS Science & Technology Co., Ltd. from December 2012 to January 2015, as a sales director at Beijing Siku Network Technology Co., Ltd.* (北京四库网络科技有限公司) from 2015 to 2019, and has served as an administrative director and practicing lawyer at Guangdong Qianhai Law Firm from 2019 to present. Ms. Zhu has extensive experience in law firm operation and management, intellectual property legal case handling, legal services, and government-client relationship management.
Board members
——
Shenzhen Neptunus Interlong Bio-Technique Co., Ltd.
Tel: (86) 75526411869
Fax: (86) 7558639160
Post code: 518000
Focus on us
Shenzhen Haiwang intelon Biotechnology Co., Ltd. All Rights Reserved
吴医师